China-based pet products producer Crazy Dog has raised RMB300 million ($43 million) in a Series B round of funding led by Guangdian Capital and Fosun International.
The previously received RMB100 million in Series A funding from Tiantu Capital, Ares Management and Xingzhen Investment in 2018. The new capital will be used to enhance the company’s online-to-offline...
India’s Innoven Capital, a joint venture between UOB and Temasek Holdings-owned Seviora Holdings, has fractionalised a USD 50m venture debt fund using blockchain and smart contracts.
OneVentures and UniQuest have led a AUD 34m (USD 23m) funding round for Vaxxas, an Australia-based biotechnology company running clinical programmes that include a needle-free COVID-19 vaccine candidate.
Temasek Holdings, A91 Partners, and Kae Capital have invested USD 135m in Indian omnichannel wellness products retailer HealthKart.